ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1254

Ultra High‐Frequency Ultrasound of Labial Salivary Glands in Primary Sjögren’s Syndrome: A Promising Tool to Identify Lymphoproliferative Lesions in Unusual Sites

Giovanni Fulvio1, Rossana Izzetti2, Francesco Ferro3, Gianmaria Governato4, Gaetano La Rocca5, Silvia Fonzetti6, Inmaculada Concepción Navarro García7, Marta Mosca8, Valentina Donati9 and Chiara Baldini1, 1University of Pisa, Pisa, Pisa, Italy, 2Unit of Dentistry and Oral Surgery, Pisa, Toscana, Italy, 3Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 4Azienda Ospedaliera Universitaria Pisana, Pisa, Pisa, Italy, 5University of Pisa, Rheumatology Unit, Palermo, Palermo, Italy, 6Azienda Ospedaliera Universitaria Pisana, Pisa, Italy, 7Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 8Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 9Pathology Unit, University of Pisa, Pisa, Italy

Meeting: ACR Convergence 2022

Keywords: B-Lymphocyte, Imaging, OMERACT, Sjögren's syndrome, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Major salivary gland (MSG) ultrasound (US) is a useful tool in Sjögren’s syndrome (SS) diagnostic work-up. Interestingly, in a recent case series, specific US findings have been associated with major salivary gland lymphoma (MSG-NHL). Similarly, Ultra High‐frequency Ultrasound (UHFUS) may detect echostructure alterations in labial salivary glands (LSG) with good diagnostic accuracy for SS. Considering that, despite rare, LSG-NHL may be incidentally detected in routine LSG biopsy. Interest has arisen in UHFUS-LSG for the early detection of LSG-NHL. At present, no data are available on LSG lymphoma (LSG-NHL) radiological features.

The aims of the study were to assess:

1) specific US features of MSG-NHL
2) specific UHFUS features of LSG-NHL
3) potential association between US findings and UHFUS findings of NHL.

Methods: From September 2017 to January 2022, consecutive pSS patients with high clinical risk for MSG lymphoma underwent US and histological examination. More recently, in the work up of LSG biopsy, UHFUS was introduced to scan LSG and to locate biopsy sites. MSG-US was performed with an 18 MHz probe, whereas UHFUS-LSG was performed with a 70 MHz probe. OMERACT score was assessed both in MSG and LSG. For suspected lesions additional ultrasonographic features were also analyzed. Patients’ clinical, biological, and histological features were collected.

Results: We included 45 consecutive pSS patients with suspected MSG-NHL (MSG group) and 34 consecutive pSS patients undergoing UHFUS-guided LSG biopsy (LSG group). Of suspected MSG-NHL, the diagnosis of NHL was confirmed in 14 patients (17 parotids and 1 submandibular gland) whereas out of 34 pSS patients undergoing UHFUS-guided LSG biopsy (LSG group), 5 atypical inflammatory infiltrate or LSG-NHL were detected (2/5 atypical inflammatory infiltrate and 3/5 labial NHLs, respectively). In MSG group, 16 MSG-NHL glands presented an OMERACT grade 3 while the other two MSG-NHL glands had a score 2. MSG-NHL appeared as very hypoechoic lesions with posterior enhancement, hyperechoic strands or septa and a high peri/intralesional doppler. In LSG group, all 5 atypical inflammatory infiltrate/LSG-NHL had OMERACT score 3, whereas the highest OMERACT score was detected only in 10/29 no-LSG-NHL patients (p=0.05). Of 5 typical inflammatory infiltrate/LSG-NHL patients, 4 presented a diffuse change, while the other patient presented a focal lesion. Atypical inflammatory infiltrate/LSG-NHL appeared as very hypoechoic lesion with high perilesional doppler.

Conclusion: LSG-NHL showed US features similar to MSG-NHL. Patients with an OMERACT score 3 in both their MSG and LSG, presenting very hypoechoic areas and high perilesional doppler, deserve a careful screening for lymphoma.

Supporting image 1

Supporting image 2


Disclosures: G. Fulvio, None; R. Izzetti, None; F. Ferro, None; G. Governato, None; G. La Rocca, None; S. Fonzetti, None; I. Navarro García, None; M. Mosca, None; V. Donati, None; C. Baldini, None.

To cite this abstract in AMA style:

Fulvio G, Izzetti R, Ferro F, Governato G, La Rocca G, Fonzetti S, Navarro García I, Mosca M, Donati V, Baldini C. Ultra High‐Frequency Ultrasound of Labial Salivary Glands in Primary Sjögren’s Syndrome: A Promising Tool to Identify Lymphoproliferative Lesions in Unusual Sites [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/ultra-high%e2%80%90frequency-ultrasound-of-labial-salivary-glands-in-primary-sjogrens-syndrome-a-promising-tool-to-identify-lymphoproliferative-lesions-in-unusual-sites/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultra-high%e2%80%90frequency-ultrasound-of-labial-salivary-glands-in-primary-sjogrens-syndrome-a-promising-tool-to-identify-lymphoproliferative-lesions-in-unusual-sites/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology